NasdaqCM - Nasdaq Real Time Price USD

Jade Biosciences, Inc. (JBIO)

8.61

+0.03

+(0.35%)

At close: May 13 at 4:00:02 PM EDT

9.04

+0.43

+(4.99%)

After hours: May 13 at 4:29:35 PM EDT

Jade Biosciences to Participate in the 2025 Jefferies Global Healthcare Conference

SAN FRANCISCO and VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”), (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced its participation in the Jefferies Global Healthcare Conference, June 3-5, 2025, in New York. Tom Frohlich, Chief Executive Officer of Jade, will deliver a company presentation on Wednesday, June 4 at 4:55-5:25 p.m. ET. Members of the management team will also

GlobeNewswire 20 hours ago

JBIO
+0.35%

Performance Overview

Return	JBIO	S&P 500 (^GSPC)
YTD	-90.47%	+0.08%
1-Year	-98.68%	+12.74%
3-Year	-98.07%	+46.29%